Home

Nuwellis, Inc. - Common Stock (NUWE)

13.83
-0.50 (-3.49%)
NASDAQ · Last Trade: Jul 24th, 1:52 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
- Video webcasts from participating companies now available here
Via ACCESS Newswire · July 22, 2025
Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030
EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END
Via FinancialNewsMedia · December 30, 2022
Nuwellis (NASDAQ: NUWE) Reports Clinical Data Showing 100% Survival Rate Using Ultrafiltration in High-Risk CABG Patients
Nuwellis, Inc. (NASDAQ: NUWE) is engaged as a medical device company, which is focused on the development and commercialization of
Via Spotlight Growth · August 31, 2022